244 related articles for article (PubMed ID: 21210639)
1. Potential effect of diaper and cotton ball contamination on NMR- and LC/MS-based metabonomics studies of urine from newborn babies.
Goodpaster AM; Ramadas EH; Kennedy MA
Anal Chem; 2011 Feb; 83(3):896-902. PubMed ID: 21210639
[TBL] [Abstract][Full Text] [Related]
2. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS; Huang PY; Ong ES; Ong CN; Li SF; Pasikanti KK; Chan EC
Rapid Commun Mass Spectrom; 2008 Aug; 22(16):2436-46. PubMed ID: 18634125
[TBL] [Abstract][Full Text] [Related]
3. NMR and MS methods for metabonomics.
Dieterle F; Riefke B; Schlotterbeck G; Ross A; Senn H; Amberg A
Methods Mol Biol; 2011; 691():385-415. PubMed ID: 20972767
[TBL] [Abstract][Full Text] [Related]
4. Nuclear magnetic resonance and liquid chromatography-mass spectrometry combined with an incompleted separation strategy for identifying the natural products in crude extract.
Dai D; He J; Sun R; Zhang R; Aisa HA; Abliz Z
Anal Chim Acta; 2009 Jan; 632(2):221-8. PubMed ID: 19110097
[TBL] [Abstract][Full Text] [Related]
5. Metabonomic study of ochratoxin a toxicity in rats after repeated administration: phenotypic anchoring enhances the ability for biomarker discovery.
Sieber M; Wagner S; Rached E; Amberg A; Mally A; Dekant W
Chem Res Toxicol; 2009 Jul; 22(7):1221-31. PubMed ID: 19610676
[TBL] [Abstract][Full Text] [Related]
6. Statistical significance analysis of nuclear magnetic resonance-based metabonomics data.
Goodpaster AM; Romick-Rosendale LE; Kennedy MA
Anal Biochem; 2010 Jun; 401(1):134-43. PubMed ID: 20159006
[TBL] [Abstract][Full Text] [Related]
7. Use of Cotton Balls in Diapers for Collection of Urine Samples Impacts the Analysis of Routine Chemistry Tests: An Evaluation of Cotton Balls, Diapers, and Chemistry Analyzers.
Thomas SN; Stieglitz HM; Hackenmueller S; Suh-Lailam B; Pyle-Eilola AL
J Pediatr; 2022 Jun; 245():179-183.e8. PubMed ID: 35248569
[TBL] [Abstract][Full Text] [Related]
8. Perspectives of 1H-NMR-based urinary metabonomics in Fabry disease.
Beneduci A; Cuccurullo M; Pontoni G; Chidichimo G; Capasso G
J Nephrol; 2010; 23 Suppl 16():S213-20. PubMed ID: 21170883
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies.
Gika HG; Theodoridis GA; Wilson ID
J Chromatogr A; 2008 May; 1189(1-2):314-22. PubMed ID: 18096175
[TBL] [Abstract][Full Text] [Related]
10. Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
Roux A; Lison D; Junot C; Heilier JF
Clin Biochem; 2011 Jan; 44(1):119-35. PubMed ID: 20800591
[TBL] [Abstract][Full Text] [Related]
11. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
[TBL] [Abstract][Full Text] [Related]
12. Alternative methods for newborn urine sample collection.
Burke N
Pediatr Nurs; 1995; 21(6):546-9. PubMed ID: 8700610
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection diagnosis using metabonomics.
Godoy MM; Lopes EP; Silva RO; Hallwass F; Koury LC; Moura IM; Gonçalves SM; Simas AM
J Viral Hepat; 2010 Dec; 17(12):854-8. PubMed ID: 20070502
[TBL] [Abstract][Full Text] [Related]
14. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer.
Lin L; Yu Q; Yan X; Hang W; Zheng J; Xing J; Huang B
Analyst; 2010 Nov; 135(11):2970-8. PubMed ID: 20856980
[TBL] [Abstract][Full Text] [Related]
15. Challenges in applying chemometrics to LC-MS-based global metabolite profile data.
Want E
Bioanalysis; 2009 Jul; 1(4):805-19. PubMed ID: 21083139
[TBL] [Abstract][Full Text] [Related]
16. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
17. Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics.
Gika HG; Theodoridis GA; Plumb RS; Wilson ID
J Pharm Biomed Anal; 2014 Jan; 87():12-25. PubMed ID: 23916607
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics: the "new clinical chemistry" for personalized neonatal medicine.
Antonucci R; Atzori L; Barberini L; Fanos V
Minerva Pediatr; 2010 Jun; 62(3 Suppl 1):145-8. PubMed ID: 21089734
[TBL] [Abstract][Full Text] [Related]
19. Time alignment algorithms based on selected mass traces for complex LC-MS data.
Christin C; Hoefsloot HC; Smilde AK; Suits F; Bischoff R; Horvatovich PL
J Proteome Res; 2010 Mar; 9(3):1483-95. PubMed ID: 20070124
[TBL] [Abstract][Full Text] [Related]
20. Processing and analysis of GC/LC-MS-based metabolomics data.
Want E; Masson P
Methods Mol Biol; 2011; 708():277-98. PubMed ID: 21207297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]